DEC 11, 2016 07:19 PM PST

Psoriasis and Heart Disease: What do the two have in common?

WRITTEN BY: Kara Marker
Psoriasis is an autoimmune disease that primarily affects the skin, but individuals with this disease are at a significantly increased risk of heart disease. How are the two systems connected? In a new study from Case Western Reserve University, researchers identified and studied the inflammatory molecules that tie the two conditions together, in hopes for developing a treatment to simultaneously treat psoriasis and prevent adverse cardiac events.
Credit: Natalie Cormier
With 1 in 50 people living with psoriasis worldwide, scientists are very invested in understanding and preventing comorbidities associated with the disease. For psoriasis patients at an increased risk of heart attacks and stroke from artery inflammation all over the body, researchers like Case Western Reserve University’s Nicole Ward, PhD, are dedicated to understanding the molecular connection, which increases an individual’s risk of thrombosis, including fatal blood clots.

Ward and her team first looked at interleukin-6 (IL-6), one type of chemical messenger incorporated by the immune system to trigger different inflammatory of anti-inflammatory pathways. In an autoimmune disease like psoriasis, it was no surprise when researchers noticed high levels of IL-6 in the skin of patients. They quickly made the connection between psoriasis and heart disease here because many patients with congestive heart failure also show signs of elevated IL-6.

In the case of psoriasis, IL-6 stimulates excessive inflammation that causes the characteristic overproduction of skin cells present in psoriasis patients. However, similar inflammation triggered by IL-6 but present in the arteries could also be causing heart disease.

However, studies in mouse models showed that removing IL-6 reduced cardiovascular risk but could not treat psoriasis successfully on its own. "Eliminating this one molecule just isn't good enough,” Ward said.
Stained section from back skin of a psoriasis mouse showing characteristic inflammatory cellular responses. Source: Case Western Reserve University School of Medicine
So if it’s not IL-6, what is the connection between the two conditions? The next suspect was a protein called MRP14, which is reliably used by scientists to predict the risk of heart attack in certain groups of people. Psoriasis patients also have high levels of MRP14 in their blood, and the gene coding for MRP14 is relatively near to the genes coding for psoriasis characteristics. MRP14 was the logical next piece of the puzzle. Could the protein be playing a role in both disease pathways?

Again, they tested in mice by knocking out the gene coding for MRP14, but researchers so no effect on skin inflammation or heart disease. "The MRP14-deficient psoriasis mice were completely the same as the regular psoriasis mice,” Ward said. “They all had similar levels of skin inflammation and thrombosis."

At this point Ward and her team knew that the culprit was neither IL-6 nor MRP14, at least not individually. There had to be another component involved, someone to drive the getaway car.

Without MRP14, mice models of psoriasis still showed high levels of IL-6 in addition to two other pro-inflammatory molecules: IL-23 and IL-17. This observation led Ward to believe that these two molecules were “helping” compensate for a lack of MRP14 in the system, making up for the loss of inflammatory molecules and maintaining the same level of skin inflammation that would occur if MRP14 were present.

Meanwhile, these two molecules were already severely under the spotlight via scientists studying and developing the newest treatments for psoriasis.  "We discovered that blocking IL-23/IL-17 decreased skin-derived IL-6 in MRP14-deficient psoriasis mice and reversed the thrombosis,” Ward said, describing the type of result she had anticipated from the studies blocking IL-6 and MRP14.

Ward then set out to identify more immune molecules influenced by the genetic deletion of IL-6 in psoriasis mice models. “It is possible that these factors also increase in psoriasis patient skin and explain why they do not respond clinically to IL-6 blockade,” Ward explained.

At first glance, the results from the first part of the study where researchers blocked the expression of IL-6 showed that although the molecule seemed to be connected to both psoriasis and its cardiac comorbidities, inhibiting the molecule would not lead to any therapeutic results. But with Ward’s study, researchers now understand both the similarities and the differences between the psoriasis and thrombosis pathways that intricately define how and when psoriasis patients experience and increased risk of heart disease.

"You have to dig deep and find something interesting from the experiments that don't work out the way you want them to,” Ward said. She and her team will continue to research IL-6, focusing on its interaction with blood and the vessel wall in relation to thrombosis.

Altogether Ward’s research was published in two different articles from the Journal of Clinical Investigation Insight and the Journal of Investigative Dermatology.
 


Sources: Case Western Reserve University, National Psoriasis Foundation
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 17, 2019
Immunology
SEP 17, 2019
Immune Messaging to Zap Sepsis
A new immune signaling molecule now provides the basis for potential new approaches in sepsis therapy....
SEP 17, 2019
Immunology
SEP 17, 2019
High Res Look Into the Brain of MS
Researchers have revealed a subtype of immune cell aiding in the autoimmune disorder Multiple Sclerosis...
SEP 17, 2019
Immunology
SEP 17, 2019
Anti-Inflammatory Meds without Side Effects, Please
Drugs such as ibuprofen or aspirin that relieve pain and lower fever are among the most frequently used drugs worldwide....
SEP 17, 2019
Health & Medicine
SEP 17, 2019
Toxic Air is Shortening Children's Lifespans
According to the State of Global Air 2019 report, air pollution is currently shortening life expectancy by an average of 20 months worldwide. This means th...
SEP 17, 2019
Immunology
SEP 17, 2019
Fecal Transplant improves ASD
Our understanding of the brain-gut connection is increasing by the day. Individuals with autism spectrum disorder (ASD) also experience gastrointestinal sy...
SEP 17, 2019
Immunology
SEP 17, 2019
New Research In Reversing Deafness
Hair cells inside the human ear are responsible for sensing and relaying sound to the brain.  In all mammals except humans, these cells can regenerate...
Loading Comments...